Frédéric Faugeroux of Ashland highlighted the global debut of Eternight, marking the company’s first time initiating a worldwide ingredient launch in China. He emphasised the importance of regional customization, noting that trends such as skin brightening remain highly relevant in China and require targeted ingredient development. Backed by a Shanghai-based clinical lab established in 2006, Ashland continues to tailor innovations to local market needs, positioning longevity as a key driver in the evolution of high-performance, consumer-focused beauty solutions.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement
















